4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-15-012404
$NBYCIK 0001389545operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:35 PM ET
Size
4.6 KB
Accession
0001437749-15-012404
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Stock Option (right to buy)
2015-06-12+24,128→ 180,362 totalExercise: $0.79From: 2015-06-30Exp: 2025-06-12→ Common Stock (24,128 underlying)
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:35 PM ET
- Size
- 4.6 KB